Skip to main content

ROYAL BANK OF CANADA

Bank

Position in VKTX — Viking Therapeutics, Inc.

CIK 1000275 TORONTO, A6

Position in VKTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$12,949,877
-$3,071,725 QoQ
Shares Held
397,968
-12.6% QoQ
Ownership
0.343%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.57911188839303.ToString("F0")% Shared 0.ToString("F0")% None 0.4208881116069633.ToString("F0")%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Sep 30, 2024
CallValue
$1,266,200
CallShares
20,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

ROYAL BANK OF CANADA holds $1,974,352,961 across 412 Biotechnology names. VKTX ranks #16 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VKTX

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,949,877 397,968
2025-12-31 $16,021,602 455,418
2025-09-30 $17,037,190 648,295
2025-06-30 $16,209,969 611,697
2025-03-31 $8,397,339 347,716
2024-12-31 $12,387,076 307,830
2024-09-30 $25,063,983 395,893
2024-09-30 $1,266,200 20,000
2024-06-30 $14,147,465 266,883
2024-06-30 $5,301,000 100,000
2024-03-31 $10,364,144 126,392
2023-12-31 $1,316,953 70,766
2023-09-30 $140,157 12,661
2023-06-30 $242,824 14,980
2023-03-31 $16,683 1,002
2022-12-31 $5,640 600
2022-09-30 $859 316
2022-06-30 $289 100
2022-03-31 $12,609 4,203
2021-12-31 $95,536 20,769
2021-09-30 $359,013 57,168
2021-06-30 $307,489 51,334
2021-03-31 $309,557 48,942
2020-12-31 $207,318 36,824
2020-09-30 $270,210 46,428
2020-06-30 $349,222 48,436
2020-03-31 $223,024 47,655